Frontlight ResearchEarly access
Trial site
Centro de Diagnóstico y Rehabilitación (CEDIR)
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Obesity8 trials
- Type 2 diabetes6 trials
- Chronic kidney disease2 trials
- Stroke2 trials
- Type 1 diabetes2 trials
- Coronary artery disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 311 trials
- Status
- Active, not recruiting7 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company11 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026